Physician profile
Mark S Pack
NPI 1952395709
$9,949.93
in general payments reported to CMS, 2019-2025
13 companies · $108 in 2025
The $108 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $246 · 2020: $118 · 2021: $7,477 · 2022: $1,032 · 2023: $875 · 2024: $93.43 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $630 · Travel and Lodging: $354 · Education: $92.16.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $629.84 |
| Travel and Lodging | $354.15 |
| Education | $92.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,934.31 | 2019-2024 | Da Vinci Sp, Da Vinci Surgical System |
| Tela Bio, INC. | $240.98 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Braintree Laboratories, INC. | $215.73 | 2020-2022 | |
| Abbott Laboratories | $140.87 | 2023-2025 | I-Stat |
| Conmed Corporation | $127.64 | 2022 | |
| Smith+Nephew, INC. | $114.22 | 2021-2023 | Grafix Pl, Stravix |
| Integra Lifesciences Corporation | $59.09 | 2019-2020 | |
| Organogenesis INC. | $49.89 | 2021-2022 | |
| Paratek Pharmaceuticals, INC. | $16.65 | 2021 | |
| Ovik Health, LLC | $16.44 | 2019 | |
| Misonix INC | $14.25 | 2020 | |
| Kci USA, INC. | $13.36 | 2020 | |
| Musculoskeletal Transplant Foundation INC. | $6.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Pack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.